Serum levels of soluble urokinase plasminogen activator receptor in Japanese patients with chronic kidney disease

Kidney International

Volumn 86, Issue 1, 2014, Pages 209-210

  Taniguchi, Yoshinori ^a   Shimamura, Yoshiko ^a   Horino, Taro ^a   Fujimoto, Shimpei ^a   Terada, Yoshio ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; UROKINASE RECEPTOR;

CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE MARKER; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HUMAN; JAPANESE (PEOPLE); KIDNEY FUNCTION; KIDNEY INJURY; LETTER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN URINE LEVEL; BLOOD; FEMALE; GLOMERULONEPHRITIS; MALE;

FEMALE; GLOMERULONEPHRITIS; HUMANS; MALE; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR;

EID: 84903736809     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.136     Document Type: Letter

References (4)

1. Wada T, Nangaku M, Maruyama S et al. A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease. Kidney Int 2014; 85: 641-648.
2. Meijers B, Maas RJ, Sprangers B et al. The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis. Kidney Int 2014; 85: 636-640.
3. Wei C, El Hindi S, Li J et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 2011; 17: 952-960.
4. Shankland SJ, Pollak MR. A suPAR circulating factor causes kidney disease. Nat Med 2011; 17: 927-927.